Zurich Cantonal Bank’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $234K | Sell |
20,230
-35
| -0.2% | -$405 | ﹤0.01% | 2056 |
|
|
2025
Q1 | $177K | Sell |
20,265
-539
| -3% | -$4.71K | ﹤0.01% | 2161 |
|
|
2024
Q4 | $299K | Sell |
20,804
-207
| -1% | -$2.97K | ﹤0.01% | 1944 |
|
|
2024
Q3 | $474K | Sell |
21,011
-960
| -4% | -$21.7K | ﹤0.01% | 1598 |
|
|
2024
Q2 | $427K | Buy |
21,971
+3,603
| +20% | +$70.1K | ﹤0.01% | 1598 |
|
|
2024
Q1 | $689K | Sell |
18,368
-948
| -5% | -$35.6K | ﹤0.01% | 1274 |
|
|
2023
Q4 | $1.08M | Sell |
19,316
-1,461
| -7% | -$81.8K | ﹤0.01% | 1025 |
|
|
2023
Q3 | $857K | Buy |
20,777
+2,419
| +13% | +$99.8K | ﹤0.01% | 1056 |
|
|
2023
Q2 | $1.03M | Buy |
18,358
+2,391
| +15% | +$134K | ﹤0.01% | 928 |
|
|
2023
Q1 | $891K | Buy |
15,967
+17
| +0.1% | +$948 | ﹤0.01% | 953 |
|
|
2022
Q4 | $581K | Buy |
15,950
+2,060
| +15% | +$75.1K | ﹤0.01% | 1165 |
|
|
2022
Q3 | $396K | Sell |
13,890
-220
| -2% | -$6.27K | ﹤0.01% | 1343 |
|
|
2022
Q2 | $638K | Sell |
14,110
-941
| -6% | -$42.5K | ﹤0.01% | 1074 |
|
|
2022
Q1 | $1.15M | Buy |
15,051
+1,732
| +13% | +$132K | 0.01% | 885 |
|
|
2021
Q4 | $1.98M | Buy |
13,319
+18
| +0.1% | +$2.68K | 0.01% | 748 |
|
|
2021
Q3 | $1.94M | Sell |
13,301
-1,538
| -10% | -$224K | 0.01% | 755 |
|
|
2021
Q2 | $2.91M | Sell |
14,839
-11,443
| -44% | -$2.24M | 0.02% | 634 |
|
|
2021
Q1 | $4.76M | Sell |
26,282
-5,402
| -17% | -$978K | 0.03% | 496 |
|
|
2020
Q4 | $4.49M | Buy |
+31,684
| New | +$4.49M | 0.03% | 525 |
|